Kobayashi Pharmaceutical Co., Ltd. increased sales and profits due to strong overseas sales in the second quarter of the fiscal year ending December 2021

 Kobayashi Pharmaceutical's financial results for the second quarter of the fiscal year ending December 2021 were a reaction to the refraining from going out due to the re-expansion of corona infection and the reaction of last year's special demand for sterilization and hygiene-related products, while the international business centered on the United States and China. Sales were strong, and sales and profits increased.

Sales increased 1.3% year-on-year to 67,052 million yen, operating income increased 0.2% to 10,240 million yen, ordinary income increased 0.6% to 11,091 million yen, and net income decreased 4.1%. It was 7,881 million yen.

Comments

Popular posts from this blog

L'Oréal forms research and technology alliance with Israeli climate tech company

"THE SONOKO White Mask" for moisturizing and transparent skin of adults

L'Oreal Research & Innovation, Morishita Jintan Co., Ltd. and L'Oreal's first successful development of cutting-edge "active delivery capsules" made of useful ingredients for plant-derived cosmetics